PDL BIOPHARMA INC - NOTE 2.750%12/0

CUSIP: 69329YAG9

Q2 2018 13F Holders as of 30 Jun 2018

Type / Class
Debt / NOTE 2.750%12/0
Market price (% of par)
91.84%
Total 13F principal
$145,958,000
Principal change
-$989,000
Total reported market value
$134,132,691
Number of holders
17
Value change
-$1,368,947
Number of buys
7
Number of sells
10

Quarterly Holders Quick Answers

What is CUSIP 69329YAG9?
CUSIP 69329YAG9 identifies 69329YAG9 - PDL BIOPHARMA INC - NOTE 2.750%12/0 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of PDL BIOPHARMA INC - NOTE 2.750%12/0 as of Q2 2018

As of 30 Jun 2018, PDL BIOPHARMA INC - NOTE 2.750%12/0 was held by 17 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $145,958,000 in principal (par value) of the bond. The largest 10 bondholders included Linden Advisors LP, Whitebox Advisors LLC, CITADEL ADVISORS LLC, WOLVERINE ASSET MANAGEMENT LLC, SMH CAPITAL ADVISORS INC, LAZARD ASSET MANAGEMENT LLC, Context Capital Management, LLC, DEUTSCHE BANK AG\, OAKTREE CAPITAL MANAGEMENT LP, and WELLS FARGO & COMPANY/MN. This page lists 17 institutional bondholders reporting positions for the Q2 2018 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.